Evaluation of Clinical Characteristics of Endovenous Sclerotherapy of Varicose Veins
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Frequency of obliteratin (total or partial) of injected varicosity.
研究概览
简要总结
The overall objective will be to evaluate clinical predictors of outcomes in patients who undergo endovenous sclerotherapy for the treatment of varicose veins.
详细描述
A prospective cohort study of patients who undergo endovenous sclerotherapy over 2 years. There are no deviations in usual clinical assessment and care of patients seeking varicose vein treatment. The purpose of this protocol is only to collect clinical and biomarker information related to this standard treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Clinical diagnosis of varicose veins
排除标准
- 未提供
结局指标
主要结局
Frequency of obliteratin (total or partial) of injected varicosity.
时间窗: assessment will be at 1, 12, and 26 weeks.
Improvement in venous stasis symptoms.
时间窗: assessment will be at 1, 12, and 26 weeks
Change in quality of life.
时间窗: assessment will be at 1, 12, and 26 weeks
Associations between clinical outcomes and biomarkers.
时间窗: assessment will be at 1, 12, and 26 weeks
次要结局
- Recurrence of varicosities.(assessment will be at 1, 12, and 26 weeks)
- Adverse events reported following procedure.(assessment will be at 1, 12, and 26 weeks)
研究者
Suman Rathbun
Professor of Medicine
University of Oklahoma